Topiramate/Phentermine Hydrochloride

托吡酯/盐酸芬特明

Report date: 2025/03/20 16:05:17

Base Information

Drug NameTopiramate/Phentermine Hydrochloride
Drug Alias Name托吡酯/盐酸芬特明Phentermine Hydrochloride and Topiramatephentermine and topiramatePhentermine/topiramateTopiramate/Phentermine Hydrochloride +[9] 
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors agonistsGlutamate receptor ionotropic AMPA antagonistsCarbonic anhydrases inhibitors +[6] 
TargetsAdrenergic receptorsGlutamate receptor ionotropic AMPACarbonic anhydrases +[6] 
Therapy Area/IndicationsBulimia NervosaBinge-Eating DisorderOverweight +[15] 
Global Approved IndicationsObesity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2012/07/17
Country/TerritoryUnited StatesUnited Arab EmiratesEU
CombinationsYes TopiramatePhentermine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVivus LLC
China Registration ClassN/A

Develop Information

Active CompaniesVivus LLCVivus IncUniversity Of Florida +[4] 
Inactive CompaniesWake Forest University Health SciencesUniversity Of MinnesotaStanford University +[4] 
Active IndicationsObesityPrediabetic StateDiabetes Mellitus, Type 2 +[5] 
Inactive IndicationsBulimia NervosaBinge-Eating DisorderOverweight +[10] 

Other Information

ATC CodeA08A
Related LinksN/A